Also, relatively reduced serum HDL/ApoA-I levels have been found in patients with lung and breast adenocarcinoma, early stage ovarian and cervical cancer, and acute lymphoblastic leukemia [84,106,117,118,119,120,126,136]. This evidence concerns the gene APOA1 and breast adenocarcinoma.